Locally Advanced Cervical Cancer Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Locally Advanced Cervical Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Phase 3

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Locally Advanced Cervical Cancer
AstraZeneca800 enrolled201 locationsNCT06079671
Recruiting
Phase 1

A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

CachexiaLocally Advanced Cervical Cancer
Second Xiangya Hospital of Central South University88 enrolled1 locationNCT07338487
Recruiting
Phase 2

QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A Phase II Trial

Neoadjuvant Treatment for Locally Advanced Cervical Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University50 enrolled1 locationNCT07286253
Recruiting
Phase 2

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

LOCALLY ADVANCED CERVICAL CANCERS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT07232654
Recruiting
Not Applicable

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

Pancreatic CancerCervical CancerLocally Advanced Cervical Carcinoma+7 more
Washington University School of Medicine60 enrolled1 locationNCT05975593
Recruiting
Phase 2

Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)

Locally Advanced Cervical Cancer
Fujian Cancer Hospital43 enrolled1 locationNCT07055399
Recruiting
Phase 2

Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer

Locally Advanced Cervical CancerFemale, Age ≥ 18 Years OldNo Previous Systemic Treatment for the Current Disease, Including Surgery, Antitumor Radiochemotherapy/Immunotherapy+6 more
The First Affiliated Hospital of Zhengzhou University29 enrolled1 locationNCT07104149
Recruiting

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

Cervical CancerLocally Advanced Cervical CancerRecurrent Cervical Cancer+1 more
MSD Italia S.r.l.200 enrolled11 locationsNCT06771193
Recruiting
Phase 3

Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer

Locally Advanced Cervical CancerGemcitabineChemo-radiotherapy
National Institute of Cancerología140 enrolled1 locationNCT06156514
Recruiting
Not Applicable

Curcumin Supplementation in Cervical Cancer

Locally Advanced Cervical Cancer
National Institute of Cancerología30 enrolled1 locationNCT06080841
Recruiting
Phase 2

Neoadjuvant Immunochemotherapy in PD-L1-negative LACC

Cervical CancerNeoadjuvant ChemoimmunotherapyLocally Advanced Cervical Cancer+1 more
Tongji Hospital40 enrolled12 locationsNCT06288360
Recruiting
Phase 2Phase 3

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Cervical CancerConcurrent ChemoradiotherapyNeoadjuvant Chemoimmunotherapy+1 more
Tongji Hospital440 enrolled12 locationsNCT06288373
Recruiting
Phase 2

Study Of Cadonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital33 enrolled1 locationNCT05687851
Recruiting
Phase 2

Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC

Locally Advanced Cervical Cancer
Tang-Du Hospital20 enrolled1 locationNCT06055738
Recruiting
Not Applicable

Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer

Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital1,956 enrolled1 locationNCT05378087
Recruiting

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Locally Advanced Cervical Cancer
Guizhou Provincial People's Hospital30 enrolled1 locationNCT05950087
Recruiting
Phase 2

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Cervical CarcinomaImmunotherapyImmune Checkpoint Inhibitor+6 more
Lei Li92 enrolled1 locationNCT05311566